Funding Opportunity PAR-22-118 from the NIH Guide for Grants and Contracts. Education programs supported by this initiative will equip scientists, health professionals and academics in low and middle-income countries with in-depth knowledge of the ethical principles, processes and policies related to international clinical and public health research.

Notice NOT-MH-22-185 from the NIH Guide for Grants and Contracts

Practical experience in one or more of the following areas: differential expression of RNAseq data for multifactor experiments, analysis of single-cell data, or…
From University of Wisconsin–Madison - Thu, 10 Mar 2022 00:58:55 GMT - View all Madison, WI jobs

A willingness to learn new assays and data analysis including basic bioinformatics will be required. Studies will include analysis of gene expression, and…
From University of Wisconsin–Madison - Thu, 10 Mar 2022 00:58:50 GMT - View all Madison, WI jobs

Notice NOT-AT-22-015 from the NIH Guide for Grants and Contracts

Notice NOT-AG-22-018 from the NIH Guide for Grants and Contracts

£35,000-44,000 per annum (DOE): Anthony Nolan: Join our Bioinformatics Research team to deliver high quality analysis, develop novel methodologies and algorithms, and provide HLA sequencing. Anthony Nolan Research Insititute, Royal Free Hospital, London

Preferred experience may include one or more of the following: care and maintenance of mouse colony, working with mouse models of infectious disease or…
From Medical College of Wisconsin - Tue, 08 Mar 2022 21:10:40 GMT - View all Milwaukee, WI jobs

Funding Opportunity PAR-22-107 from the NIH Guide for Grants and Contracts. The Centers of Excellence in Genomic Science (CEGS) program establishes academic Centers for advanced genome research. Each CEGS award supports a multi-investigator, interdisciplinary team to develop transformative genomic approaches to address a biomedical problem. A CEGS project will address a critical issue in genomic science, genomic medicine, or computational genomics, proposing a highly innovative solution that would be a major advance. The research will entail substantial risk, balanced by outstanding scientific and management plans and very high potential payoff. A CEGS will focus on the development of novel technological or computational methods for the production or analysis of comprehensive data sets, on a genome-scale biomedical problem, or on other ways to develop and use genomic approaches for understanding biological systems or furthering the application of genomic knowledge, data, and methods towards clinical applications. Each CEGS will nurture genomics at its institution by facilitating the interaction of investigators from several disciplines. By training new and experienced investigators it will expand the pool of genomics scientists and engineers.

Funding Opportunity PAR-22-123 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies. The goal of the program is to support technological innovations that deliver new capabilities which can realize meaningful solutions within 5 10 years.

Notice NOT-AI-22-039 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-22-015 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide resources to support the time and effort of transdisciplinary teams in collaboration with communities and clinics to develop a cancer prevention and control research program and provide training to junior investigators that focuses on and serves populations in persistent poverty. The long-term goal of this initiative is to build capacity in persistent poverty areas to foster cancer prevention and control research and promote the implementation of programs and practices in communities to alleviate the effects of persistent poverty.

Notice NOT-HD-22-004 from the NIH Guide for Grants and Contracts

Notice NOT-NR-22-012 from the NIH Guide for Grants and Contracts

Notice NOT-AT-22-014 from the NIH Guide for Grants and Contracts

Notice NOT-AI-22-036 from the NIH Guide for Grants and Contracts

Notice NOT-AG-22-016 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-22-135 from the NIH Guide for Grants and Contracts. The National Eye Institute (NEI) Audacious Goal Initiative (AGI) is an effort to push the boundaries of vision science and restore vision through regeneration of cells in the retina. AGI research specifically targets photoreceptors (PRCs) and retinal ganglion cells (RGCs) in the eye. Photoreceptors often called rods and cones are cells in the retina that, when stimulated by light, generate signals the brain perceives as images. The retinal ganglion cells carry these signals from the photoreceptors to the brain. Although there has been some success in regenerating retinal neurons and connections in fish, mice, and other systems, the ultimate goal of the AGI is to restore vision in humans.

Notice NOT-NS-22-076 from the NIH Guide for Grants and Contracts

Notice NOT-OD-22-089 from the NIH Guide for Grants and Contracts